Wei Chen is a Nephrology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study
Sponsor: The University of Texas Medical Branch, Galveston
- Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20252 payments$211
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Thiazide-like diuretic48.8%Chlorthalidone100%Part D<11 patientsAngiotensin receptor blocker (ARB)25.6%Losartan Potassium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2003–2025 per NIH RePORTER. The latest:
- Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease
Albert Einstein College of Medicine
FY2025$756,659R01HL172073 - Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease
Albert Einstein College of Medicine
FY2024$783,483R01HL172073 - Cellular Interactions in Vascular Calcification of Chronic Kidney Disease
Albert Einstein College of Medicine
FY2023$126,000R03DK131246
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
Paul Kimmel, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”